420 with CNW — Key Lessons from the Marijuana Liberalization Journey of the US

The journey toward cannabis legalization in the United States has been significant, with nearly half of the states now allowing its recreational use. However, the topic remains contentious and divisive, frequently leveraged by politicians. Some invoke fears about potential harm to oppose legalization, while others emphasize benefits such as increased revenue and reduced violent crime to advocate for it.

Scientific research on marijuana-related harms is relatively comprehensive. Regular consumption of high-potency marijuana, especially when initiated at a young age, is linked to mental health issues, including schizophrenia. It may also lead to cognitive difficulties, reduced academic performance, and an elevated risk of marijuana use disorder.

Consuming marijuana before driving—particularly within an eight-hour window—significantly raises the likelihood of traffic accidents. Additionally, cannabis use while pregnant has been associated with complications at birth.

A key question in this debate is how legalization influences these risks. The potency of cannabis, which directly impacts its harmful effects, has been rising in states with legal markets. This trend toward high-potency products began during cannabis prohibition in both Europe and the U.S. Some evidence also suggests that legal dispensaries may overstate potency levels to attract customers.

Marijuana use appears higher in states where it is legal, though this does not necessarily mean that legalization causes increased use. Research paints a mixed picture. While adult usage rates tend to rise after legalization, most studies show little to no change in marijuana use among adolescents. One complicating factor is that marijuana use has been on the rise since 2000, well before legalization became a trend.

A concerning trend tied to legalization is a rise in ER visits related to marijuana-induced psychosis and unintentional poisoning in youngsters. These incidents are more common in areas with a high density of marijuana stores and are partly attributed to the popularity of edible products, often designed to look like candy.

The question of marijuana legalization is not black and white. Decisions about drug policy can significantly influence both the prevalence of use and the societal impact. Lessons can be drawn from Uruguay, which legalized marijuana in 2012 while implementing strict regulations. The country has not seen a notable increase in marijuana use, addiction rates, or perceived harm compared to its neighbors.

Additionally, discussions on legalization must weigh the drawbacks of prohibition. Criminal organizations often profit from the illicit drug trade, fueling violence and expanding their reach. Research shows that strict drug law enforcement does not effectively prevent marijuana use and may even exacerbate related harms.

Ultimately, there is no flawless approach to drug policy, and substances like marijuana are likely to remain a part of society. Policymakers should adopt an evidence-based and balanced approach, learning from global examples to create thoughtful marijuana regulations that minimize harm and prioritize public health.

This balanced approach is precisely what the cannabis industry, including leading players like Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF), wish for every jurisdiction that is considering reforming its marijuana laws through voter initiatives or the legislature.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Archives

Select A Month

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722